Tango Therapeutics director John B. Ketchum reports sale of $80,258.64 in common shares
TNGX•Director John B. Ketchum sold 3,333 Tango Therapeutics shares on Nov. 17, 2026, at $24.08 per share, leaving him with direct beneficial ownership of 21,604 shares.
1. Share sale
John B. Ketchum sold 3,333 shares of Tango Therapeutics common stock on Nov. 17, 2026, at $24.08 per share. He retained direct beneficial ownership of 21,604 shares.




